19396016Lara PN, Longmate J, Evans CP, Quinn DI, Twardowski P, Chatta G, Posadas E, Stadler W, Gandara DRAnti-cancer drugsAdenocarcinoma; Antineoplastic Agents; Benzodioxoles; Prostatic Neoplasms; Protein Kinase Inhibitors; Quinazolines; src-Family KinasesAged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Gastrointestinal Diseases; Humans; Lymphopenia; Male; Middle Aged; Orchiectomy; Prostate-Specific AntigenA phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study. Anticancer Drugs. 2009 Mar; 20(3):179-84.Anticancer Drugs2009-03-01T00:00:002009A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000230Disorders29111600.582288AdenocarcinomaD000369Living Beings93664810.461329Aged, 80 and overD000368Living Beings1341183530.29479AgedD000970Chemicals & Drugs40723510.435494Antineoplastic AgentsD000726Chemicals & DrugsPhysiology411400.907145Androgen AntagonistsD003131Procedures38816800.739615Combined Modality TherapyD005767Disorders1081450.875941Gastrointestinal DiseasesD008231Disorders25280.984772LymphopeniaD009919Procedures32670.97051OrchiectomyD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD011471Disorders23517080.438692Prostatic NeoplasmsAuthorship 379708D006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleD019008Physiology1805890.751147Drug Resistance, Neoplasm0.08791580.08791581authors10.2522has subject areaD017430Chemicals & Drugs953460.825516Prostate-Specific AntigenD019061Chemicals & Drugs48740.969863src-Family KinasesD018931Chemicals & Drugs631500.911777Antineoplastic Agents, HormonalD011799Chemicals & Drugs652200.877248QuinazolinesD052117Chemicals & Drugs14160.980939BenzodioxolesD056486Disorders44680.939478Chemical and Drug Induced Liver InjuryD018572Concepts & Ideas25812030.792724Disease-Free SurvivalD047428Chemicals & Drugs2065890.714226Protein Kinase InhibitorsMedicineUniversity of ChicagoWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.Professortrue1ProfessorProfessor